Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Shares Issued (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Shares Issued for 13 consecutive years, with $927335.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Issued changed N/A year-over-year to $927335.0, compared with a TTM value of $2.0 million through Sep 2025, changed N/A, and an annual FY2024 reading of $906000.0, up 83.11% over the prior year.
  • Shares Issued was $927335.0 for Q2 2025 at BioRestorative Therapies, down from $1.1 million in the prior quarter.
  • Across five years, Shares Issued topped out at $7.5 million in Q1 2024 and bottomed at $9.0 in Q3 2023.
  • Average Shares Issued over 3 years is $1.9 million, with a median of $927335.0 recorded in 2025.
  • Peak annual rise in Shares Issued hit 85.6% in 2025, while the deepest fall reached 85.6% in 2025.
  • Year by year, Shares Issued stood at $83073.0 in 2023, then surged by 8961.94% to $7.5 million in 2024, then plummeted by 87.68% to $927335.0 in 2025.
  • Business Quant data shows Shares Issued for BRTX at $927335.0 in Q2 2025, $1.1 million in Q1 2025, and $7.5 million in Q1 2024.